Business Context and Reporting Period
This Form 8-K was filed by Tharimmune, Inc. (not Canton Strategic Holdings, Inc.) on November 17, 2023. The registrant is a Delaware corporation with its principal executive offices in Bridgewater, NJ, and its common stock trades on The Nasdaq Capital Market under the symbol "THAR". The company is classified as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding a corporate action and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Reverse Stock Split: The Company filed a Certificate of Amendment to effect a 1-for-25 reverse stock split of its issued and outstanding common stock.
- Effective Date: The split became effective at 4:01 p.m. Eastern time on November 20, 2023.
- Trading Resumption: Commencing November 21, 2023, the stock began trading on a post-split basis under the existing symbol "THAR".
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future performance, or specific risk factors beyond the standard disclosure of the reverse split. The primary purpose of the report is to disclose the amendment to the Certificate of Incorporation and the associated press release.
Investor Verification Checklist
- Verify the post-split share count and adjusted share price on November 21, 2023.
- Confirm that the trading symbol remains "THAR" on The Nasdaq Capital Market.
- Review the attached Certificate of Amendment (Exhibit 3.1) for any other changes to the Certificate of Incorporation.
- Check subsequent filings for updated financial data, as this 8-K contains no financial metrics.